Publikationen, an denen er mitarbeitet María Luisa Navarro Gómez (12)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

2023

  1. Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations

    Anales de Pediatria, Vol. 98, Núm. 1, pp. 58.e1-58.e10

2022

  1. Immunisation schedule of the Pediatric Spanish Association: 2022 recommendations

    Anales de Pediatria, Vol. 96, Núm. 1, pp. 59.e1-59.e10

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations

    Anales de Pediatria, Vol. 94, Núm. 1, pp. 53.e1-53.e10

2020

  1. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  2. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  3. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

  4. Immunisation schedule of the Spanish Association of Paediatrics: 2020 recommendations

    Anales de Pediatria, Vol. 92, Núm. 1, pp. 52.e1-52.e10

2018

  1. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  2. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337